Dimensional Fund Advisors
BBIO icon

Dimensional Fund Advisors’s BridgeBio Pharma BBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.7M Buy
561,945
+179,376
+47% +$13M 0.01% 1596
2025
Q4 		$29.3M Buy
382,569
+314,316
+461% +$20.6M 0.01% 1788
2025
Q3 		$3.55M Sell
68,253
-33,534
-33% -$1.64M ﹤0.01% 2630
2025
Q2 		$4.4M Buy
101,787
+5,305
+5% +$193K ﹤0.01% 2566
2025
Q1 		$3.34M Buy
96,482
+34,817
+56% +$1.17M ﹤0.01% 2607
2024
Q4 		$1.69M Sell
61,665
-1,036
-2% -$26.8K ﹤0.01% 2828
2024
Q3 		$1.6M Sell
62,701
-10,529
-14% -$276K ﹤0.01% 2832
2024
Q2 		$1.85M Buy
73,230
+3,624
+5% +$99.1K ﹤0.01% 2775
2024
Q1 		$2.15M Buy
69,606
+21,977
+46% +$747K ﹤0.01% 2778
2023
Q4 		$1.92M Buy
47,629
+2,234
+5% +$67.1K ﹤0.01% 2798
2023
Q3 		$1.2M Buy
+45,395
New +$1.29M ﹤0.01% 2880
2022
Q1 		– Sell
-31,467
Closed -$525K – 3512
2021
Q4 		$525K Sell
31,467
-154,971
-83% -$6.56M ﹤0.01% 3154
2021
Q3 		$8.74M Buy
186,438
+36,789
+25% +$1.97M ﹤0.01% 2390
2021
Q2 		$9.12M Buy
149,649
+69,143
+86% +$3.95M ﹤0.01% 2407
2021
Q1 		$4.96M Buy
80,506
+47,835
+146% +$3.13M ﹤0.01% 2586
2020
Q4 		$2.32M Buy
+32,671
New +$1.58M ﹤0.01% 2765
2020
Q3 		– Sell
-30,700
Closed -$1M – 3333
2020
Q2 		$1M Sell
30,700
-3,639
-11% -$111K ﹤0.01% 2941
2020
Q1 		$996K Buy
34,339
+26,353
+330% +$817K ﹤0.01% 2893
2019
Q4 		$280K Buy
+7,986
New +$221K ﹤0.01% 3220

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's BBIO Position: Q1 2026 in Review

Dimensional Fund Advisors increased its BridgeBio Pharma (BBIO) stake by 47% in Q1 2026, buying an estimated $13M and bringing the position to 561,945 shares worth $41.7M. The position accounts for 0.01% of the portfolio, ranked #1596.

Dimensional Fund Advisors first reported a position in BBIO in Q4 2019 and has held it in 19 quarters since. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Dimensional Fund Advisors held 561,945 shares of BridgeBio Pharma worth $41.7M as of Q1 2026.
  • Dimensional Fund Advisors bought 179,376 BridgeBio Pharma shares in Q1 2026, an estimated $13M.
  • BridgeBio Pharma made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1596 holding.
  • Dimensional Fund Advisors first reported a position in BridgeBio Pharma in Q4 2019 and has held it in 19 quarters since.
  • 458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.